Related Experiment Video
Updated: May 17, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Comprehensive management of vulvovaginal cancers
Angélica Nogueira-Rodrigues1,2,3,4,5, Maaike H M Oonk6, Domenica Lorusso7
1Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Vulvar and vaginal cancers are rare, often linked to human papillomavirus (HPV). Treatment focuses on surgery, but options for recurrent disease are limited, highlighting the need for better therapies.
Area of Science:
- Gynecologic Oncology
- Cancer Etiology and Treatment
Background:
- Vulvar cancer (2.7/100,000 women) and vaginal cancer (<1% of female cancers) are rare malignancies.
- Squamous cell carcinoma, often HPV-associated, comprises 90% of vulvar cancers.
- Rising incidence in younger demographics necessitates updated treatment strategies.
Purpose of the Study:
- To review the etiology, histopathology, and treatment of vulvar and vaginal cancers.
- To highlight current treatment limitations and future directions.
- To emphasize the need for improved systemic therapies and supportive care.
Main Methods:
- Literature review focusing on etiology, histopathology, and treatment strategies.
- Analysis of current evidence from retrospective studies and phase 2 trials.
- Extrapolation of data from cervical cancer treatment protocols.
Main Results:
- Surgery is the primary treatment for vulvar cancer, with chemoradiation for locally advanced cases.
- Recurrence rates range from 12-37% within 2 years.
- Systemic treatment for recurrent/metastatic disease is limited, with 5-year survival around 20%.
Conclusions:
- Current evidence is limited, underscoring the need for clinical trial enrollment.
- Best supportive care is crucial for quality of life.
- Future HPV vaccination may reduce incidence, but enhanced treatment efficacy is urgently needed.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Disorders of the Female Reproductive System

